An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.
- DOI
- 10.1002/cam4.1388
- Published
- 2018 May
- Container
- Cancer medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.1388,
title = {An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.},
author = {Vacirca JL and Chan A and Mezei K and Adoo CS and Pápai Z and McGregor K and Okera M and Horváth Z and Landherr L and Hanslik J and Hager SJ and Ibrahim EN and Rostom M and Bhat G and Choi MR and Reddy G and Tedesco KL and Agajanian R and Láng I and Schwartzberg LS},
year = {2018},
journal = {Cancer medicine},
doi = {10.1002/cam4.1388},
url = {https://doi.org/10.1002/cam4.1388}
}RIS
TY - JOUR TI - An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer. AU - Vacirca JL AU - Chan A AU - Mezei K AU - Adoo CS AU - Pápai Z AU - McGregor K AU - Okera M AU - Horváth Z AU - Landherr L AU - Hanslik J AU - Hager SJ AU - Ibrahim EN AU - Rostom M AU - Bhat G AU - Choi MR AU - Reddy G AU - Tedesco KL AU - Agajanian R AU - Láng I AU - Schwartzberg LS PY - 2018 JO - Cancer medicine DO - 10.1002/cam4.1388 UR - https://doi.org/10.1002/cam4.1388 ER -
APA
JL, V., A, C., K, M., CS, A., Z, P., K, M., M, O., Z, H., L, L., J, H., SJ, H., EN, I., M, R., G, B., MR, C., G, R., KL, T., R, A., I, L., & LS, S. (2018). An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.. Cancer medicine. https://doi.org/10.1002/cam4.1388
Source records
- pubmed · retrieved 2026-09-26T04:09:40.004Z